Tamsulosin HCl SR Pellets

Welcome to the forefront of urological care with PharmAlliance International Labs’ Tamsulosin HCl SR Pellets. Crafted with precision, our pellets offer relief from benign prostatic hyperplasia (BPH) symptoms by targeting alpha-1 adrenergic receptors in the prostate. Packaged conveniently in capsules, each containing 0.4mg of tamsulosin hydrochloride, our sustained-release pellets ensure consistent efficacy with once-daily dosing. Patients can trust in our commitment to excellence as we revolutionize urological health worldwide.



Revolutionizing Urological Health with PharmAlliance International Labs’ Tamsulosin HCl SR Pellets

Welcome to a New Era in Urological Care

PharmAlliance International Labs welcomes you to explore our groundbreaking advancements in urological health with our Tamsulosin HCl SR Pellets. Crafted with precision and innovation, our Tamsulosin range is engineered to alleviate the symptoms of benign prostatic hyperplasia (BPH), offering enhanced comfort and relief to individuals worldwide. With a steadfast commitment to excellence and patient well-being, we strive to deliver pharmaceutical solutions that redefine the standards of urological care.

Understanding the Science Behind Tamsulosin HCl SR Pellets

Tamsulosin HCl is a potent alpha-1 adrenergic receptor antagonist, targeting the alpha-1A and alpha-1D subtypes predominant in the prostate gland. By selectively blocking these receptors, Tamsulosin induces smooth muscle relaxation in the prostate, bladder neck, and urethra, thereby easing urinary obstruction and facilitating improved urinary flow. Our sustained-release (SR) pellets ensure a controlled and prolonged release of the medication, providing consistent relief from BPH symptoms.

Unveiling the Drug Classification

Tamsulosin HCl is classified as an alpha-1 adrenergic receptor antagonist, specifically indicated for the treatment of signs and symptoms associated with benign prostatic hyperplasia (BPH). These symptoms may include urinary hesitancy, weak stream, incomplete bladder emptying, and urinary frequency or urgency.

The Formulation Designed for Efficacy and Convenience

Our Tamsulosin HCl SR Pellets are encapsulated in convenient capsules, each containing 0.4mg of tamsulosin hydrochloride. Engineered for sustained-release, these pellets offer prolonged efficacy with once-daily dosing, enhancing patient convenience and compliance.

Navigating Usage and Dosage

Patients are advised to orally administer Tamsulosin HCl SR Pellets with water, ideally 30 minutes after the same meal daily to optimize absorption and minimize orthostatic hypotension risks. The recommended dosage entails one capsule (0.4mg) daily, with dosing adjustments guided by individual response and tolerability under the supervision of healthcare providers.

Exploring Potential Side Effects

While generally well-tolerated, Tamsulosin may elicit some side effects, including dizziness, headache, fatigue, ejaculation disorders, nasal congestion, and gastrointestinal disturbances. Patients are encouraged to promptly report any persistent or concerning side effects to their healthcare providers for appropriate management.

Packaging Specifications Ensuring Convenience

Our Tamsulosin HCl SR Pellets are meticulously packaged in blister packs, each containing 10 capsules. This packaging format ensures convenient storage, administration, and adherence to prescribed regimens.

Partner with PharmAlliance International Labs for Enhanced Urological Care

Trust PharmAlliance International Labs to deliver effective urological solutions, elevating the quality of life for individuals grappling with benign prostatic hyperplasia. With our Tamsulosin HCl SR Pellets Range, patients can embark on a journey towards improved urinary comfort and well-being. Join us in our mission to redefine urological care and empower individuals worldwide to experience enhanced urological health and vitality.



There are no reviews yet.

Be the first to review “Tamsulosin HCl SR Pellets”

Your email address will not be published. Required fields are marked *

Pharmalliance.pkĀ© 2024. All rights reserved. Terms of use and Privacy Policy